Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review

ConclusionsConcomitant use of dupilumab with long-acting beta agonists used in combination with inhaled corticosteroids, improves clinical outcomes and quality of life in patients with moderate to severe asthma. Although dupilumab has a promising role in treatment of patients with asthma, it is still in the emerging stage for its acceptance globally. Ongoing studies will help to determine dupilumab's long-term efficacy and safety for its future extensive use.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research